Q-Centrix

Q-Centrix

Q-Centrix was established to address the growing complexity of clinical data management within US healthcare systems. The firm provides technology and services that help hospitals capture, normalize, and report clinical data for quality registries, value-based care programs, and regulatory compliance. Its offering spans data abstraction, analytics, and consulting, with a focus on cardiovascular, oncology, and surgical specialties. Public records do not identify a named founder, founding year, or wealth origin for the firm. The firm's strategy centers on a data-as-a-service model, combining software with clinical expertise to convert raw hospital data into structured insights. It operates across multiple US regions, serving both academic medical centers and community hospitals. Client engagements typically involve long-term contracts for data abstraction and registry reporting. The firm’s service model does not appear to involve direct investment in portfolio companies or fund commitments. Team size and professionals count are not publicly available. No additional offices beyond Portsmouth are documented. No philanthropic or adjacent operating vehicles have been disclosed in public filings or press. No recent operational events from the last 24 months could be verified. The structural differentiator for Q-Centrix is its narrow specialization within healthcare data — a domain with high barriers to entry due to regulatory complexity and the need for clinical domain expertise. The firm operates more as a service provider than an asset manager or investment vehicle, which distinguishes it from traditional family offices or private equity firms. Without disclosed ownership or funding sources, its governance and capital structure remain opaque.